Concepedia

Dimitrios Sionis

DS

Statistics

Publications

10

Citations

747

H-Index

10

Active since

1991

Affiliations

University of Colorado Denver(Current)

Regeneron (United States)

Canadian VIGOUR Centre

Inserm

University of Alabama at Birmingham

Dimitrios Sionis is an author at University of Colorado Denver specializing in medicine, cardiovascular disease, and cardiology.

Publications per year

1991–2022

10

Publications

10

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

, , +15

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

, , +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

, , +17

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner et al. · Diabetes Care · 2021 · 38 citations · Full text

, , +17

Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study

Katerina Κ. Naka, Aris Bechlioullis, Aikaterini Marini et al. · Journal of clinical lipidology · 2017 · 30 citations

, , +16

1–5 of 10